Status:
UNKNOWN
Group Intervention on Executive Function in Children With Autism Spectrum Disorder
Lead Sponsor:
Istituto per la Ricerca e l'Innovazione Biomedica
Collaborating Sponsors:
Fondazione di Comunità di Messina onlus
Conditions:
Autism Spectrum Disorder
Autism
Eligibility:
All Genders
7-13 years
Phase:
NA
Brief Summary
Autism is a developmental disorder characterized by difficulties in social communication, repetitive behaviors, and social interaction. A key aspect of autism concerns executive functions, which are a...
Eligibility Criteria
Inclusion
- Children with diagnosis of autism and autism spectrum disorder
Exclusion
- Presence of other medical disorders
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2024
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05977075
Start Date
December 1 2022
End Date
March 31 2024
Last Update
August 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)
Messina, Italy, 98164